company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3433000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3433000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,508000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,764000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,836000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,706000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6247000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6247000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-356000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-273000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1943000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1255000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1870000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,553000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,553000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6783000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6783000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6783000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,17000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,173000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,136000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,87000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-995000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,941000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,941000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,92000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-725000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,523000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-206000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-206000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-13197000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15586000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2389000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2389000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,61000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5275000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5275000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,525000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,625000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,541000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-621000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6345000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6345000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-333000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-688000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2550000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1153000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2418000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2418000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-13655000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15586000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1931000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1931000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5874000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,61000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1585000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1585000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,93000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,134000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,395000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2249000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2249000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,18000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1825000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1806000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1806000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,2244000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2244000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2244000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3735000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3735000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,352000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,489000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,454000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,374000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5404000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5404000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-238000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-780000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1825000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,630000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2212000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2212000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-458000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-458000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-458000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-12 16:57:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2734000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1267000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1267000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,176000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,159000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-160000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1561000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1561000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-94000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-109000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-202000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-202000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1326000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1326000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1326000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2150000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2150000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,259000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,355000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,412000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-21000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3155000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3155000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-256000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-780000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,630000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-406000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-406000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2702000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2702000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2702000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-09 14:48:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,47000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,883000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,883000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,179000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,253000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,139000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1594000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1594000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-162000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-671000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,629000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-204000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-204000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1376000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1376000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1376000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,388000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,509000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,584000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,658000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6267000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6267000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-491000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1335000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2705000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,879000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,879000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-914000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-320000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2555000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,347000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3442000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3442000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-10000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3694000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,283000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1305000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,99000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,101000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,91000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-174000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1245000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1245000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-151000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,358000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-704000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,620000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,123000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,123000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-201000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-641000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,103000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-747000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-747000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,620000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,283000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1305000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,462000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,544000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,580000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-163000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5963000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5963000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-435000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-266000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1356000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2608000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,550000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,550000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-14103000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1914000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15586000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,244000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-306000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-306000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6214000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,61000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,97000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,137000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,257000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,343000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1798000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1798000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-133000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-224000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-617000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-29000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,2000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-640000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,54000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-613000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-613000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,11000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,232000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3000000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3000000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,289000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,408000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,493000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,832000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-340000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-358000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-631000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2085000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,756000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,756000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-906000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1914000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,244000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2695000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2695000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-07 16:09:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3074000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5161000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5161000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,458000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,541000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,365000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-111000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6414000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6414000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-284000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-42000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2564000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2598000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-292000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-292000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11830000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-121000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1274000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15586000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,190000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2551000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2551000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8669000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,61000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1068000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1068000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,100000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,136000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,135000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,598000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2037000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2037000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-134000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,233000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,233000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,63000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-24000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-638000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,99000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-6000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1764000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2036000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2036000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,192000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,271000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,236000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,489000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3224000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3224000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-207000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-134000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2075000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1720000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1720000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-877000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-121000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1274000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,190000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2082000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2082000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-20000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-07 17:03:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2842000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,477000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,581000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,389000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-869000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5938000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5938000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-259000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-17000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2550000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2099000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-727000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-727000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-13219000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-97000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-636000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15586000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,91000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1725000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1725000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6938000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,61000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,968000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,968000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,92000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,135000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,101000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-109000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1187000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1187000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-88000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1575000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1487000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1487000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-940000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-97000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-636000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,91000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1582000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1582000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-14000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1078000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1774000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1774000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,383000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,403000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1777000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-788000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3549000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3549000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-612000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1791000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1477000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-926000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-926000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-70000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-806000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2661000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,232000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3293000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3293000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1247000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,498000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-810000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-810000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,97000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,96000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,681000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-642000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-578000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-578000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-153000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2700000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2514000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2514000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,84000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-372000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-674000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,68000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-882000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-882000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-425000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,629000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,498000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2584000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2584000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,286000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,307000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1096000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-146000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4127000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4127000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-459000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1741000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1460000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2700000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3440000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3440000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-154000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-434000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1987000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,164000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2411000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2411000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-152000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-06 13:40:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1876000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3712000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3712000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,385000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,408000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1187000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-320000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5372000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5372000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-610000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,358000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2445000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2080000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2700000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3317000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3317000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-162000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-635000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2628000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,267000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3158000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3158000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-153000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1256000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,283000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1305000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,506000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,506000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,94000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,98000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,986000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,102000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1786000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1786000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-180000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-564000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1160000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2700000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2284000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2284000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,51000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-81000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-673000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-53000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,37000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-719000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-719000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-150000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1367000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4170000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4170000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,388000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,447000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,458000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-79000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5384000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5384000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-563000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,134000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2498000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,930000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1997000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1997000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-242000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-552000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,53000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,284000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3052000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3052000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,343000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,283000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1305000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1098000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1098000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,103000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,99000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,51000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1717000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1717000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-142000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-517000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,300000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-359000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-359000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,205000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-24000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-673000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,35000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,42000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-415000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-415000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,946000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2078000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2078000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,192000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,209000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,110000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-248000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2341000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2341000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-279000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1177000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,300000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1156000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1156000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-205000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-353000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1314000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,53000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,127000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1692000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1692000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-07 13:58:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-509000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,385000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,484000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,542000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,153000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5704000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5704000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1995000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1130000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1405000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1405000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-384000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-552000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2560000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,18000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,341000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3137000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3137000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1161000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,283000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1305000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,980000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,980000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,89000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,59000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-614000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,624000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,624000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-137000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-660000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-797000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-797000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-410000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-329000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-641000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,18000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,85000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1277000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1277000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1455000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5144000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5144000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,417000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1051000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,504000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7535000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7535000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-532000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-11488000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1815000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,899000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12936000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12936000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4037000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7768000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3294000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,20696000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,155000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5752000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5752000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-300000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,51000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,536000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1108000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1517000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1517000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,121000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,173000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1963000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1963000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-145000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-170000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-297000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-297000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1247000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-840000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3646000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,32000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2431000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2431000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-59000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-824000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,536000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1108000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3627000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3627000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,296000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,279000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,878000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,492000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5572000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5572000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-387000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-11488000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1645000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,881000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12639000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12639000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-15000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-6521000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2454000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,17050000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,123000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8183000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8183000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-241000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-07 12:52:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,875000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2817000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2817000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,393000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,375000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1559000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-150000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4994000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4994000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-11488000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1695000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,898000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2700000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10125000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10125000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,69000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-6893000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,17062000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,191000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7301000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7301000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-666000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1504000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,498000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,102000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,125000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,159000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,530000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2155000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2155000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-127000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,872000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,745000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,745000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,421000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-998000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-850000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,349000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,22000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1056000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1056000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-21000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1823000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2388000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2388000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,194000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,154000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,719000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-38000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3417000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3417000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-260000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-11488000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1645000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13384000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13384000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-436000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5523000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1604000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,16701000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,101000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-220000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-05 12:24:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-948000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2084000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2084000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,385000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,348000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2386000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-578000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4625000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4625000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-593000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-11488000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2259000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1186000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13154000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13154000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-301000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5976000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2951000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,16660000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,206000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7638000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7638000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-795000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1686000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,498000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,104000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,86000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,224000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,52000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1832000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1832000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-115000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10752000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1645000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12511000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12511000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-436000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5122000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-818000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,16491000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,54000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10169000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10169000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-506000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,90000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,68000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,495000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-90000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1585000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1585000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-145000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-736000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-873000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-873000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-401000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-786000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,210000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,47000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-930000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-930000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-224000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-442000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1816000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1816000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,384000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,361000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2213000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-264000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4510000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4510000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-620000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-736000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1131000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1485000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1002000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1002000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,340000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-878000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2806000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,204000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,194000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2946000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2946000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-796000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-234000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,498000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5953000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5953000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,425000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,764000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1461000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7041000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7041000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-479000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2495000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2359000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6074000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6074000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6033000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-6102000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3717000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,11656000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,268000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3928000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3928000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-338000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3299000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,986000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3563000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1391000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1391000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,210000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,228000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-406000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1541000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1541000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-114000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-18000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-885000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,780000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3621000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1827000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-933000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3821000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,58000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2502000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2502000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-38000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,986000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3563000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4562000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4562000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,307000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,554000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1132000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1055000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-365000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2477000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4692000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1579000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5955000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5955000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2412000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4275000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2784000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7835000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,210000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1426000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1426000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-300000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-07 11:27:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2181000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6079000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6079000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,428000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,694000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1305000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1043000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7463000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7463000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-510000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2477000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4862000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1597000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6252000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6252000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6434000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5522000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3624000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,11481000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,242000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3857000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3857000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-359000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3005000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,536000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1108000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1598000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1598000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,96000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,208000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,401000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-849000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1454000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1454000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-113000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-22000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,476000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-199000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-199000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-407000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-6000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-933000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-66000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,41000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1371000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1371000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-109000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,211000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,346000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,731000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-206000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4046000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4046000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-252000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2455000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4152000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1103000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5756000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5756000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2005000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4269000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1851000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7901000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,169000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-55000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-55000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-307000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-07 12:15:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2072000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5720000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5720000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,434000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,611000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1063000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,336000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8164000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8164000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-524000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2455000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4322000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1993000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5308000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5308000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5606000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-6514000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3541000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,11896000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,223000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3542000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3542000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-387000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1073000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,536000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1108000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1610000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1610000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,108000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,181000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,332000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-307000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1924000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1918000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-131000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2427000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2810000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1070000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4298000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4298000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1999000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3860000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-927000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7858000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,92000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1164000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1164000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-13000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1229000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1354000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1354000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,103000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,165000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,399000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,101000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2122000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-121000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-28000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1342000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,33000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1458000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1458000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-409000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-924000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,43000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,77000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1219000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1219000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-294000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-843000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5476000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5476000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,430000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,516000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,955000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,695000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8072000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8078000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-508000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10780000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3157000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,924000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13521000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13521000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4043000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7776000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3432000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,20529000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,185000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5463000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5463000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-370000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-350000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,536000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1108000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5309000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5309000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,425000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1076000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2515000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,635000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9960000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9960000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-529000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2538000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2793000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-274000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-274000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-25000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1410000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-4107000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,44000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-14000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5512000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5512000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,29000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4203000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1099000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1696000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,52000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,101000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,268000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2215000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-52000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2584000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2584000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-182000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-520000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,903000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,201000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,201000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-505000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1030000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-426000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,40000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1928000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1928000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,857000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1099000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1696000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5257000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5257000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,324000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,808000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,300000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7376000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7376000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-347000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2018000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1890000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-475000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-475000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-905000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3077000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,470000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-54000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3584000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3584000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,29000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-07 12:45:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3346000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6648000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6648000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,442000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1018000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,528000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,281000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8917000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8917000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-461000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-18000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2903000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2670000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-594000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-594000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3639000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2732000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-4010000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4291000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6086000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6086000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2228000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,986000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3563000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1631000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1631000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,111000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,268000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-104000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1365000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3271000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3271000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-126000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-527000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,544000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-109000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-109000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1026000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,429000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-203000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-810000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-810000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2358000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3626000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3626000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,213000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,404000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-678000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4105000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4105000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-221000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1491000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1346000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-13000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-900000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2051000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,41000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,149000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2774000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2774000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,23000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-07 13:14:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,988000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6615000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6615000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,427000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,958000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1033000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1933000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7100000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7100000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-448000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-40000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2916000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2602000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-684000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-684000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4041000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2733000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3917000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3796000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,248000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6647000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6647000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-8000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,986000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3563000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1915000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1915000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,110000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,269000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,190000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-481000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2003000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2003000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-126000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-458000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,902000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,318000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,318000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1024000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-8000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,64000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-980000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-980000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1348000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1711000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1711000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,103000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,271000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,214000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-197000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2102000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2102000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1033000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,444000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-684000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-684000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-895000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1027000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,49000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,85000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1794000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1794000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6310000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6310000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,425000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,870000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1175000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1759000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7021000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7015000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-453000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2467000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5268000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2770000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5300000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5300000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6033000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-6588000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3820000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,11662000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,276000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4503000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4503000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-28000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2816000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,986000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3563000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,471000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1294000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7052000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1077000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13427000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13427000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-638000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2528000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2160000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1006000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1006000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6035000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-12054000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-5580000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9278000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-14396000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-14396000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-39000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2014000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1215000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,122000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,320000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5567000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-791000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3392000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3392000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-123000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-406000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,246000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-283000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-283000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-614000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2064000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1451000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,297000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3825000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3825000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-10000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-726000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1215000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7513000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7513000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,349000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,974000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1485000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-286000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10035000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10035000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-515000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2122000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1914000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-723000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-723000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5421000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-9990000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-4129000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8981000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10571000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10571000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-29000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-06 10:16:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1288000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7565000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7565000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,450000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1242000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3700000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-338000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12619000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12619000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-697000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2642000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2817000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-522000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-522000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5428000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10495000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-5159000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8555000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,28000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-12499000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-12499000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-29000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-431000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1099000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1696000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2747000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2747000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,115000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,320000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,435000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,907000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4524000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4524000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-282000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1084000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,403000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-963000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-963000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2408000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1043000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1461000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5865000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-37000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,916000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,916000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4468000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4766000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4766000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,234000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,654000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1050000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1193000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5511000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5511000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-233000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1038000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1511000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,240000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,240000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3013000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-8947000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2668000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3116000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,25000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11487000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11487000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-20000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-05 12:33:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5756000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6449000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6449000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,446000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1190000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3161000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,120000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,11366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,11366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-541000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2085000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2958000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,332000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,332000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3025000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-9457000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-4724000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-138000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-14225000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-14225000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-14000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2541000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1099000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1696000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1983000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1983000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,324000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,657000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-217000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2866000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2866000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-114000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-399000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1200000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2973000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7516000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1531000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3079000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-37000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8978000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8978000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-35000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5460000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2783000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2783000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,115000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,330000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,393000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-976000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2645000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2645000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-639000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,311000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-447000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-447000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-40000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1431000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1137000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,37000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,62000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2509000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2509000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,15000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-296000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6381000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6381000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,437000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1135000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2694000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-144000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10503000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10503000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-553000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2144000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2660000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-59000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1946000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-4217000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,32000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-37000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6227000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6227000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,28000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4267000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1099000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1696000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2801000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2801000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,353000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-113000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,116000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3275000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3275000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-163000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-663000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,167000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-615000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-615000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1531000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-178000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,29947000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-41000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26602000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26602000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,14000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29276000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1794000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1447000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7882000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7882000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,464000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1553000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1663000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1762000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13324000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13324000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-552000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1718000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2699000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,167000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,596000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,596000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5235000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1053000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-6366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,31517000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-155000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,18708000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,18708000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32635000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1794000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1447000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3255000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3255000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,468000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1520000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7343000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,855000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13441000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13441000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-512000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1461000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2901000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,928000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,928000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4318000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2939000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-6222000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1867000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-107000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11719000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11719000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-17000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2633000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1215000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1884000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1884000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,114000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,427000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1189000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,941000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4555000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4555000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-154000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1378000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1378000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-307000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-81000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1591000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1549000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-441000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-441000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-16000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5476000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5081000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5081000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,346000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1200000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1776000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1646000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10049000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10049000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-389000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1055000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2655000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1211000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1211000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3704000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-875000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-4771000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1570000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-114000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7894000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7894000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-06 10:16:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3359000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,469000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1413000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,821000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13410000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13410000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-640000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2488000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1715000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1413000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1413000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6419000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3901000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-6092000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6183000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-133000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10362000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10362000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-10000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1625000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1215000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,741000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,741000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,114000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,388000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,236000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,998000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2477000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2477000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-484000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,472000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-197000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-174000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1592000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-107000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2070000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2070000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,275000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3197000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3197000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,232000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,773000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,587000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,705000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5494000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5494000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-235000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-998000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1066000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-167000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-167000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3397000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-794000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3180000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,21000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-103000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7453000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7453000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,9000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-05 12:33:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2117000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2456000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2456000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,385000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,351000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-293000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3017000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3017000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-107000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-514000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,594000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3200000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-620000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1588000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,21000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5383000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5383000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2392000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,474000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1349000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7010000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-394000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13799000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13799000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-626000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2403000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2443000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-586000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-586000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9195000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-11243000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-6031000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9262000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-63000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-17270000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-17270000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-53000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4110000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1215000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8436000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8436000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,461000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1612000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1572000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2041000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14122000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14122000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-570000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1229000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2131000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,162000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,494000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,494000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2035000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1076000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-6541000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,31521000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-200000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,21669000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,21669000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-40000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36245000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1794000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1447000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3010000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3010000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,115000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,444000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,260000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3815000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3815000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-125000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-129000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-129000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-643000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1763000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,25000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-41000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2422000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2422000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-46000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1218000000.0
